NeurologyCardiovascularBiopharmaBiotechnologyHealth Care
Description
Cytokinetics, Incorporated (Cytokinetics) operates as a late-stage biopharmaceutical company. The company focuses on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatme…
Analysis
Middle-of-the-road
Cytokinetics, Incorporated is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
Valuation data is not available for this company.
The trajectory is moderate and the balance sheet is stretched. The company scores 7/20 on our value-creation score: creating some value. Analyst sentiment is cautious.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202624
49
2026
All-time high
49
Jun 2026
All-time low
24
Mar 2026
Average rank
37
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
42
—
—
—
Price/Earnings
83
—
—
—
Price/Book
87
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
73
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.